Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CARDIAC ALLOGRAFT SURVIVAL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 81 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Morelli, AE; Hackstein, H; Thomson, AW
      Potential of tolerogenic dendritic cells for transplantation

      SEMINARS IN IMMUNOLOGY
    2. Wood, KJ; Jones, ND; Bushell, AR; Morris, PJ
      Alloantigen-induced specific immunological unresponsiveness

      PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    3. Nakagawa, K; Matsuno, T; Iwagaki, H; Morimoto, Y; Fujiwara, T; Sadamori, H; Inagaki, M; Urushihara, N; Yagi, T; Tanaka, N
      Donor dendritic cells and recipient kupffer cells in the induction of donor-specific immune hyporesponsiveness

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    4. Chen, J; Huoam, C; Plain, K; He, XY; Hodgkinson, SJ; Hall, BM
      CD4(+), CD25(+) T cells as regulators of alloimmune responses

      TRANSPLANTATION PROCEEDINGS
    5. Hall, BM; Chen, J; Robinson, C; He, XY; Plain, K; Verma, N; Hodgkinson, ST
      Conditioned dendritic cells as a temporal bridge between T helper and cytotoxic cells

      TRANSPLANTATION PROCEEDINGS
    6. Takayama, T; Tahara, H; Thomson, AW
      Differential effects of myeloid dendritic cells retrovirally transduced toexpress mammalian or viral interleukin-10 on cytotoxic T lymphocyte and natural killer cell functions and resistance to tumor growth

      TRANSPLANTATION
    7. Takeuchi, H; Yoshikawa, M; Kanda, S; Nonaka, M; Nishimura, F; Yamada, T; Ishizaka, S; Sakaki, T
      Implantation of xenografts into the parkinsonian rat brain after portal venous administration of xenogeneic donor spleen cells

      JOURNAL OF NEUROSURGERY
    8. Hara, M; Kingsley, CI; Niimi, M; Read, S; Turvey, SE; Bushell, AR; Morris, PJ; Powrie, F; Wood, KJ
      IL-30 is required for regulatory T cells to mediate tolerance to alloantigens in vivo

      JOURNAL OF IMMUNOLOGY
    9. Philosophe, B; Farney, AC; Schweitzer, EJ; Colonna, JO; Jarrell, BE; Krishnamurthi, V; Wiland, AM; Bartlett, ST
      Superiority of portal venous drainage over systemic venous drainage in pancreas transplantation: A retrospective study

      ANNALS OF SURGERY
    10. Ardehali, A; Reddy, R; Laks, H
      Gene therapy and heart transplantation

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    11. Steptoe, RJ; Patel, RK; Subbotin, VM; Thomson, AW
      Comparative analysis of dendritic cell density and total number in commonly transplanted organs: morphometric estimation in normal mice

      TRANSPLANT IMMUNOLOGY
    12. Waldmann, TA
      T-cell receptors for cytokines: Targets for immunotherapy of leukemia/lymphoma

      ANNALS OF ONCOLOGY
    13. Hirano, A; Fraser, MO; Jordan, ML; Takayama, T; Lu, L; Thomson, AW
      Graft hyporeactivity induced by donor-derived dendritic cell progenitors

      TRANSPLANTATION PROCEEDINGS
    14. Yamada, K; Shimizu, A; Utsugi, R; Ierino, FL; Gargollo, P; Haller, GW; Colvin, RB; Sachs, DH
      Thymic transplantation in miniature swine. II. Induction of tolerance by transplantation of composite thymokidneys to thymectomized recipients

      JOURNAL OF IMMUNOLOGY
    15. Gummert, JF; Ikonen, T; Morris, RE
      Newer immunosuppressive drugs: A review

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    16. Kirk, AD
      Transplantation tolerance: A look at the nonhuman primate literature in the light of modern tolerance theories

      CRITICAL REVIEWS IN IMMUNOLOGY
    17. Lu, L; Lee, WC; Takayama, T; Qian, SG; Gambotto, A; Robbins, PD; Thomson, AW
      Genetic engineering of dendritic cells to express immunosuppressive molecules (viral IL-10, TGF-beta, and CTLA4Ig)

      JOURNAL OF LEUKOCYTE BIOLOGY
    18. Qi, Z; Tufveson, G; Ekberg, H
      Tolerance or rejection: A delicate balance as judged by exposure of heart-transplanted rats to the immunomodulator Linomide (R)

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    19. Olausson, M; Lukes, D; Norrby, J; Qi, Z; Ekberg, H; Gannedahl, G; Tufveson, G; Mjornstedt, L
      Antithymocyte globulin and cyclosporin A are synergistic in an experimental transplantation tolerance model in the rat

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    20. Douillard, P; Cuturi, MC; Brouard, S; Josien, R; Soulillou, JP
      T cell receptor repertoire usage in allotransplantation: An overview

      TRANSPLANTATION
    21. He, L; Gotoh, M; Dono, K; Nagano, H; Ota, H; Ohta, Y; Okuyama, M; Takeda, Y; Shimizu, J; Grochowiecki, T; Sakon, M; Monden, M
      Participation of the liver in generation of a vigorous anti-donor responseafter inoculation of donor spleen cells

      TRANSPLANTATION
    22. Takayama, T; Tahara, H; Thomson, AW
      Transduction of dendritic cell progenitors with a retroviral vector encoding viral interleukin-10 and enhanced green fluorescent protein allows purification of potentially tolerogenic antigen-presenting cells

      TRANSPLANTATION
    23. Rossini, AA; Greiner, DL; Mordes, JP
      Induction of immunologic tolerance for transplantation

      PHYSIOLOGICAL REVIEWS
    24. Martin, S; Vinke, A; Heidenthal, E; Schulte, B; van den Engel, N
      Development of low-dose streptozotocin-induced diabetes in ICAM-1-deficient mice

      HORMONE AND METABOLIC RESEARCH
    25. Wiseman, LR; Faulds, D
      Daclizumab - A review of its use in the prevention of acute rejection in renal transplant recipients

      DRUGS
    26. FAROOQ A; ANJUM S; CHOUDHARY MI; ATTAURRAHMAN
      DEGRADATIVE AND SYNTHETIC STUDIES ON RAPAMYCIN - A POTENT IMMUNOSUPPRESSANT

      CURRENT ORGANIC CHEMISTRY
    27. WALDMANN TA; OSHEA J
      THE USE OF ANTIBODIES AGAINST THE IL-2 RECEPTOR IN TRANSPLANTATION

      Current opinion in immunology
    28. BUMGARDNER GL; LI JS; APTE S; HEININGER M; FRANKEL WL
      EFFECT OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERCELLULAR-ADHESION MOLECULE-1 EXPRESSION ON IMMUNOGENICITY OF MURINE LIVER-CELLS IN MICE

      Hepatology
    29. GRAEB C; SCHERER MN; KNECHTLE SJ; GEISSLER EK
      IMMUNOLOGICAL SUPPRESSION MEDIATED BY GENETICALLY-MODIFIED HEPATOCYTES EXPRESSING SECRETED ALLO-MHC CLASS-I MOLECULES

      Human immunology
    30. GRUESSNER RWG; NAKHLEH RE; HARMON JV; DUNNING M; GRUESSNER AC
      DONOR-SPECIFIC PORTAL BLOOD-TRANSFUSION IN INTESTINAL TRANSPLANTATION- A PROSPECTIVE, PRECLINICAL LARGE ANIMAL STUDY

      Transplantation
    31. PUNCH JD; TONO T; QIN LH; BISHOP DK; BROMBERG JS
      TOLERANCE INDUCTION BY ANTI-CD2 PLUS ANTI-CD3 MONOCLONAL-ANTIBODIES -EVIDENCE FOR AN IL-4 REQUIREMENT

      The Journal of immunology (1950)
    32. KONIGSBERG PJ; GODTEL R; KISSEL T; RICHER LL
      THE DEVELOPMENT OF IL-2 CONJUGATED LIPOSOMES FOR THERAPEUTIC PURPOSES

      Biochimica et biophysica acta. Biomembranes
    33. HAMANO K; ITO H; BUSHELL A; WOOD KJ; ESATO K
      THE INDUCTION OF OPERATIONAL TOLERANCE IS NOT PREVENTED BY SIMULTANEOUS ADMINISTRATION OF CYCLOSPORINE-A

      Transplant international
    34. FREDE SE; VALENTE J; ALEXANDER JW; BABCOCK GF
      THE RELATIONSHIP OF BLOOD-TRANSFUSION AND IMMUNOSUPPRESSION TO THE TH1 TH2 PARADIGM/

      Transplantation proceedings
    35. YU S; NAKAFUSA Y; FLYE MW
      IN-VITRO ANALYSIS OF GADOLINIUM CHLORIDE ABROGATION OF THE SYSTEMIC TOLERANCE INDUCED BY PORTAL VENOUS ADMINISTRATION OF ULTRAVIOLET B-IRRADIATED DONOR CELLS

      Transplantation
    36. PLAIN KM; FAVA L; SPINELLI A; HE XY; CHEN JC; BOYD R; DAVIDSON CL; HALL BM
      INDUCTION OF TOLERANCE WITH NONDEPLETING ANTI-CD4 MONOCLONAL-ANTIBODIES IS ASSOCIATED WITH DOWN-REGULATION OF TH2 CYTOKINES

      Transplantation
    37. LANGREHR JM; NUSSLER NC; NEUMANN U; GUCKELBERGER O; LOHMANN R; RADTKE A; JONAS S; KLUPP J; STEINMULLER T; LOBECK H; MEUER S; SCHLAG H; LEMMENS HP; KNOOP M; KECK H; BECHSTEIN WO; NEUHAUS P
      A PROSPECTIVE RANDOMIZED TRIAL COMPARING INTERLEUKIN-8 RECEPTOR ANTIBODY VERSUS ANTITHYMOCYTE GLOBULIN AS PART OF A QUADRUPLE IMMUNOSUPPRESSIVE INDUCTION THERAPY FOLLOWING ORTHOTOPIC LIVER-TRANSPLANTATION

      Transplantation
    38. VINCENTI F; LANTZ M; BIRNBAUM J; GAROVOY M; MOULD D; HAKIMI J; NIEFORTH K; LIGHT S
      A PHASE-I TRIAL OF HUMANIZED ANTI-INTERLEUKIN 2 RECEPTOR ANTIBODY IN RENAL-TRANSPLANTATION

      Transplantation
    39. PILSON RS; LEVIN W; DESAI B; REIK LM; LIN P; KORKMAZDUFFY E; CAMPBELL E; TSO JY; KERWIN JA; HAKIMI J
      BISPECIFIC HUMANIZED ANTI-IL-2 RECEPTOR-ALPHA-BETA ANTIBODIES INHIBITORY FOR BOTH IL-2-MEDIATED AND IL-15-MEDIATED PROLIFERATION

      The Journal of immunology
    40. GUEXCROSIER Y; RABER J; CHAN CC; KRIETE MS; BENICHOU J; PILSON RS; KERWIN JA; WALDMANN TA; HAKIMI J; ROBERGE FG
      HUMANIZED ANTIBODIES AGAINST THE ALPHA-CHAIN OF THE IL-2 RECEPTOR ANDAGAINST THE BETA-CHAIN SHARED BY THE IL-2 AND IL-15 RECEPTORS IN A MONKEY UVEITIS MODEL OF AUTOIMMUNE-DISEASES

      The Journal of immunology
    41. STADLBAUER THW; KUPIECWEGLINSKI JW
      IMMUNOBIOLOGY OF SENSITIZATION IN TRANSPLANT RECIPIENTS

      The American journal of the medical sciences
    42. PAGANI FD; BOLLING SF
      CTLA4-IG - PROGRESS WITH A NOVEL IMMUNOSUPPRESSIVE AGENT IN EXPERIMENTAL SOLID-ORGAN TRANSPLANTATION

      Biodrugs
    43. VANGELDER T; WEIMAR W
      POTENTIAL OF ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODIES IN SOLID-ORGAN TRANSPLANTATION

      Biodrugs
    44. MAGGIOPRICE L; POLLACK SB; SHIOTA F; THOULESS M; MOAZED TC; GROSSMANN A
      CHARACTERIZATION OF NATURAL-KILLER-CELL ACTIVITY IN MACACA-NEMESTRINA

      American journal of primatology
    45. CHUNG SW; GOULD B; GORCZYNSKI R
      THE ROLE OF ICAM-1 IN THE INDUCTION OF ANTIGEN-SPECIFIC T-CELL HYPORESPONSIVENESS

      Immunology letters
    46. TERZIOGLU E; CHUNG S; COHEN Z; FU XM; LEVY G; GORCZYNSKI RM
      ALTERED SERUM CYTOKINES IN HEPATIC AND PORTAL BLOOD OF RATS AT EARLY TIMES FOLLOWING PORTAL VENOUS INFUSION OF SEMI-ALLOGENEIC CELLS

      Immunology letters
    47. JENSEN JE; JENSEN PB; NIELSEN B; KOCH C; LARSEN S; HORN T; KEMP E
      INDUCED TOLERANCE AND FLOW-CYTOMETRY ANALYSIS OF LYMPHOCYTE PHENOTYPES IN CONCORDANT XENOGRAFT TRANSPLANTATION

      Transplantation proceedings
    48. GHOBRIAL RR; HAMASHIMA T; WANG ME; WANG M; STEPKOWSKI SM; KAHAN BD
      INDUCTION OF TRANSPLANTATION TOLERANCE BY CHIMERIC DONOR RECIPIENT CLASS-I RT1.A(A) MOLECULES/

      Transplantation
    49. GRANT SCD; LAMB WR; BROOKS NH; BRENCHLEY PEC; HUTCHINSON IV
      SERUM CYTOKINES IN HUMAN HEART-TRANSPLANT RECIPIENTS - IS THERE A RELATIONSHIP TO REJECTION

      Transplantation
    50. MARSHALL SE; COBBOLD SP; DAVIES JD; MARTIN GM; PHILLIPS JM; WALDMANN H
      TOLERANCE AND SUPPRESSION IN A PRIMED IMMUNE-SYSTEM

      Transplantation
    51. BABCOCK GF; ALEXANDER JW
      THE EFFECTS OF BLOOD-TRANSFUSION ON CYTOKINE PRODUCTION BY TH1 AND TH2 LYMPHOCYTES IN THE MOUSE

      Transplantation
    52. SAITOVITCH D; BUSHELL A; MABBS DW; MORRIS PJ; WOOD KJ
      KINETICS OF INDUCTION OF TRANSPLANTATION TOLERANCE WITH A NONDEPLETING ANTI-CD4 MONOCLONAL-ANTIBODY AND DONOR-SPECIFIC TRANSFUSION BEFORE TRANSPLANTATION - A CRITICAL PERIOD OF TIME IS REQUIRED FOR DEVELOPMENTOF IMMUNOLOGICAL-UNRESPONSIVENESS

      Transplantation
    53. GORCZYNSKI RM; ADAMS RB; LEVY GA; CHUNG SW
      CORRELATION OF PERIPHERAL-BLOOD LYMPHOCYTE AND INTRAGRAFT CYTOKINE MESSENGER-RNA EXPRESSION WITH REJECTION IN ORTHOTOPIC LIVER-TRANSPLANTATION

      Surgery
    54. GRIMMINGER F; GRIMM H; FUHRER D; PAPAVASSILIS C; LINDEMANN G; BLECHER C; MAYER K; TABESCH F; KRAMER HJ; STEVENS J; SEEGER W
      OMEGA-3 LIPID INFUSION IN A HEART ALLOTRANSPLANT MODEL - SHIFT IN FATTY-ACID AND LIPID MEDIATOR PROFILES AND PROLONGATION OF TRANSPLANT SURVIVAL

      Circulation
    55. NISCO SJ; HISSINK RJ; VRIENS PW; HOYT EG; REITZ BA; CLAYBERGER C
      IN-VIVO STUDIES OF THE MAINTENANCE OF PERIPHERAL TRANSPLANT TOLERANCEAFTER CYCLOSPORINE - RADIOSENSITIVE ANTIGEN-SPECIFIC SUPPRESSOR CELLSMEDIATE LASTING GRAFT PROTECTION AGAINST PRIMED EFFECTOR-CELLS

      Transplantation
    56. TALMOR M; STEINMAN RM; CODNER MA; CHEN M; HARPER AD; WITMERPACK MD; HOFFMAN LA
      BONE-MARROW-DERIVED CHIMERISM IN NONIRRADIATED, CYCLOSPORINE-TREATED RATS RECEIVING MICROVASCULARIZED LIMB TRANSPLANTS - EVIDENCE FOR DONOR-DERIVED DENDRITIC CELLS IN RECIPIENT LYMPHOID-TISSUES

      Immunology
    57. VOSSEN ACTM; SAVELKOUL HFJ
      CYTOKINES IN CLINICAL AND EXPERIMENTAL TRANSPLANTATION

      Mediators of inflammation
    58. CHARLTON B; AUCHINCLOSS H; FATHMAN CG
      MECHANISMS OF TRANSPLANTATION TOLERANCE

      Annual review of immunology
    59. BOCK GH; NEU L; LONG C; PATTERSON LT; KORB S; GELPI J; NELSON DL
      AN ASSESSMENT OF SERUM AND URINE SOLUBLE INTERLEUKIN-2 RECEPTOR CONCENTRATIONS DURING RENAL-TRANSPLANT REJECTION

      American journal of kidney diseases
    60. KNULST AC; NOORT WA; TIBBE GJM; BENNER R; SAVELKOUL HFJ
      PREVENTION OF LETHAL GRAFT-VERSUS-HOST DISEASE IN MICE BY MONOCLONAL-ANTIBODIES DIRECTED TO T-CELLS OR THEIR SUBSETS .2. DIFFERENTIAL EFFECTIVENESS OF IGG2A AND IGG2B ISOTYPES OF ANTI-CDS AND ANTI-CD4 MOAB

      Bone marrow transplantation
    61. BASELGA J; MENDELSOHN J
      RECEPTOR BLOCKADE WITH MONOCLONAL-ANTIBODIES AS ANTICANCER THERAPY

      Pharmacology & therapeutics
    62. BASELGA J; MENDELSOHN J
      RECEPTOR BLOCKADE WITH MONOCLONAL-ANTIBODIES AS ANTICANCER THERAPY

      Pharmacology & therapeutics
    63. GRIMM H; TIBELL A; NORRLIND B; BLECHER C; WILKER S; SCHWEMMLE K
      IMMUNOREGULATION BY PARENTERAL LIPIDS - IMPACT OF THE N-3 TO N-6 FATTY-ACID RATIO

      JPEN. Journal of parenteral and enteral nutrition
    64. UDA M; FUJIWARA T; KUSAKA S; MATSUNO T; TANAKA N; ORITA K
      DONOR-SPECIFIC INHIBITORY FACTOR-INDUCED BY PORTAL VENOUS INOCULATIONWITH ULTRAVIOLET-B IRRADIATED SPLEEN-CELLS IN NONHUMAN-PRIMATES

      Transplantation proceedings
    65. TAKARA T; TCHERVENKOV JI; GUTTMAN FM; FECTEAU A; ROSENMANN E
      INTRAPORTAL DONOR-SPECIFIC TRANSFUSION GIVEN 24 HOURS BEFORE SMALL-BOWEL TRANSPLANTATION WITH CYCLOSPORINE AND FK-506

      Transplantation proceedings
    66. BOGERS WMJM; LANG F; PARKER KE; LEMAUFF B; ANEGON I; JACQUES Y; SOULILLOU JP
      RAT INTERLEUKIN-2 IMMUNOGLOBULIN-M FUSION PROTEINS ARE CYTOTOXIC IN-VITRO FOR CELLS EXPRESSING THE IL-2 RECEPTOR AND CAN ABOLISH CELL-MEDIATIED IMMUNITY IN-VIVO

      Transplantation
    67. BOGERS WMJM; LANG F; PARKER KE; LEMAUFF B; ANEGON I; JACQUES Y; SOULILLOU JP
      RAT INTERLEUKIN-2 IMMUNOGLOBULIN-M FUSION PROTEINS ARE CYTOTOXIC IN-VITRO FOR CELLS EXPRESSING THE IL-2 RECEPTOR AND CAN ABOLISH CELL-MEDIATIED IMMUNITY IN-VIVO

      Transplantation
    68. FECTEAU AH; TCHERVENKOV JI; GUTTMAN FM; TAKARA T; ROSENMANN E
      SMALL-BOWEL TRANSPLANTATION - THE EFFECT OF INTRAPORTAL DONOR-SPECIFIC TRANSFUSION 24 HOURS PRETRANSPLANT AND LOW-DOSE CYCLOSPORINE

      Transplantation
    69. HAMASHIMA T; STEPKOWSKI SM; SMITH S; KAHAN BD
      INDUCTION OF TRANSPLANTATION TOLERANCE BY A SINGLE INTRATHYMIC INJECTION OF 3M KCL-EXTRACTED DONOR HISTOCOMPATIBILITY ANTIGENS COMBINED WITH 2 DOSES OF ANTI-RAT ALPHA BETA-T CELL-RECEPTOR MONOCLONAL-ANTIBODIES/

      Transplantation
    70. KRENSKY AM; CLAYBERGER C
      TRANSPLANTATION IMMUNOLOGY

      The Pediatric clinics of North America
    71. KREITMAN RJ; BAILON P; CHAUDHARY VK; FITZGERALD DJP; PASTAN I
      RECOMBINANT IMMUNOTOXINS CONTAINING ANTI-TAC(FV) AND DERIVATIVES OF PSEUDOMONAS EXOTOXIN PRODUCE COMPLETE REGRESSION IN MICE OF AN INTERLEUKIN-2 RECEPTOR-EXPRESSING HUMAN CARCINOMA

      Blood
    72. KROEMER G; DEALBORAN IM; GONZALO JA; MARTINEZ C
      IMMUNOREGULATION BY CYTOKINES

      Critical reviews in immunology
    73. NAKAFUSA Y; TERASAKA R; MATSUO K; KONOMI K; FLYE MW
      ADVANTAGES OF DONOR-SPECIFIC BLOOD-TRANSFUSION IN THE RAT VIA THE PORTAL-VEIN FOR RENAL-TRANSPLANTATION

      American journal of kidney diseases
    74. WALDMANN TA
      THE IL-2 IL-2 RECEPTOR SYSTEM - A TARGET FOR RATIONAL IMMUNE INTERVENTION/

      Immunology today
    75. VANDEVYVER C; STEUKERS M; LAMBRECHTS J; HEYLIGEN H; RAUS J
      DEVELOPMENT AND FUNCTIONAL-CHARACTERIZATION OF A MURINE HUMAN CHIMERIC ANTIBODY WITH SPECIFICITY FOR THE HUMAN INTERLEUKIN-2 RECEPTOR

      Molecular immunology
    76. STRIETER RM; KUNKEL SL; BONE RC
      ROLE OF TUMOR-NECROSIS-FACTOR-ALPHA IN DISEASE STATES AND INFLAMMATION

      Critical care medicine
    77. NAGANO H; MONDEN M; GOTOH M; TANIGAWA T; TONO T; NAKANO Y; MORI T
      INDUCTION OF UNRESPONSIVENESS IN RATS AFTER EITHER INTRAPORTAL INJECTION OF DONOR ANTIGEN OR INTRAVENOUS-INJECTION COMBINED WITH SPLENECTOMY

      Transplantation
    78. WHITEHEAD BF; STOEHR C; WU CJ; PATTERSON G; BURCHARD EG; THEODORE J; CLAYBERGER C; STARNES VA
      CYTOKINE GENE-EXPRESSION IN HUMAN LUNG-TRANSPLANT RECIPIENTS

      Transplantation
    79. NEUHAUS P; BECHSTEIN WO; BLUMHARDT G; WIENS M; LEMMENS P; LANGREHR JM; LOHMANN R; STEFFEN R; SCHLAG H; SLAMA KJ; LOBECK H
      COMPARISON OF QUADRUPLE IMMUNOSUPPRESSION AFTER LIVER-TRANSPLANTATIONWITH ATG OR IL-2 RECEPTOR ANTIBODY

      Transplantation
    80. ROLAND CR; MANGINO MJ; FLYE MW
      LANTHANIDE BLOCKADE OF ANTIGEN-PRESENTING CELLS SUPPRESSES LYMPHOCYTE-PROLIFERATION BY INDUCING NITRIC-OXIDE SYNTHESIS

      The Journal of surgical research
    81. WALDMANN TA
      THE IL-2 IL-2 RECEPTOR SYSTEM - A TARGET FOR RATIONAL IMMUNE INTERVENTION/

      Trends in pharmacological sciences


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/06/20 alle ore 03:59:06